Global osteoporosis treatment market is estimated to be valued at USD 14.91 Bn in 2024 and is expected to reach USD 19.84 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
To learn more about this report, request sample copy
Introduction of novel therapeutics and self-administrable formulations are expected to boost the market growth. However, availability of generic medicines and patent expiration of blockbuster drugs may hamper the market growth. Emphasis on the development of anabolic drugs, osteoporosis treatment in premenopausal women, and rising awareness regarding the disease are expected to create lucrative opportunities for the market players in the near future.
Increasing Incidence of Osteoporosis
Increasing prevalence and incidence of osteoporosis is expected to drive the market growth during the forecast period. For instance, according to the International Osteoporosis Foundation, osteoporosis causes more than 8.9 billion fractures annually worldwide, resulting in an osteoporosis fracture every 3 seconds.
Increasing awareness campaigns is expected to drive the market growth over the forecast period. For instance, in February 2022, the Royal Osteoporosis Society, UK's national charity launched a national campaign to raise awareness about osteoporosis and the importance of bone health among Parliamentarians and NHS leaders.
Osteoporosis Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients